Glaukos is committed to investing in the future of ophthalmology to transform the standard of care and improve patient lives. Our dedication to continuous innovation has resulted in an unrivaled pipeline of novel therapies. #Glaukos
Glaukos Corporation’s Post
More Relevant Posts
-
Unlock the secrets to successful ophthalmology clinical operations with First in Human: The Panel Series. Hear from leading experts on collaboration, protocol development, and overcoming trial challenges. Watch here: https://lnkd.in/d2Xh-8TZ
To view or add a comment, sign in
-
Dr. Rajat N Agrawal, discusses the transformative potential of technology in ophthalmology clinical trials, emphasizing streamlined patient experiences and reduced burdens on site staff for improved trial outcomes. View the whole conversation here: https://lnkd.in/gTmXU_2g
To view or add a comment, sign in
-
🔬👁️ Dr. Baruch D. Kuppermann reflects on a pivotal shift in clinical research, triggered by recent changes in trial endpoints for dry AMD treatments. This 'sea change' opens up vast opportunities for innovation, encouraging companies beyond just Stealth BioTherapeutics to develop treatments that meet these new standards—potentially transforming care for one of ophthalmology's greatest unmet needs. Anticipate more durable, less frequent treatments as a result of this advancement. #Ophthalmology #ClinicalResearch #Innovation RIWC24: Retina International World Congress 2024
To view or add a comment, sign in
-
As a passionate advocate for cutting-edge medical technology, I'm thrilled by the performance of RadiusXR, a game-changer in the field of visual field testing. 💡 Let's dive into the technical differentiators: 1️⃣ Precision Engineering: Unlike other virtual reality perimeters (VRPs) that repurpose consumer-grade gaming headsets, RadiusXR is meticulously designed and manufactured specifically for ophthalmology. This ensures optimal performance and reliability, giving clinicians the assurance they need in their diagnostic tools. 🔬 2️⃣ Unparalleled Accuracy: Our NOVA Clinical Trial has demonstrated a remarkable 0.94 correlation in mean deviation and statistical non-inferiority for glaucoma staging compared to traditional methods. This level of accuracy is a game-changer in diagnosing and managing ocular conditions, empowering clinicians with actionable insights to improve patient outcomes. 📊Read the peer-reviewed publication in the Journal of Translational Vision Science and Technology published by the Association for Research in Vision and Ophthalmology (ARVO). 3️⃣ Photopic Range Measurement: One of our key differentiators is our ability to measure vision within the photopic range, aligning perfectly with existing visual field platforms' standards. This ensures consistent clinical training and facilitates comparison to patients' prior examinations, ultimately enhancing outcomes. 🌟 4️⃣ Innovation in Action: RadiusXR is not just pushing boundaries but redefining them. This technology combines spatial computing with precision engineering to deliver unparalleled accuracy and reliability. From glaucoma staging to monitoring disease progression, RadiusXR is paving the way for a brighter future in ocular health. #RadiusXR #Innovation #OcularHealth #MedicalTechnology #VisionaryTech
🎉 Big News Alert! 🎉 Thrilled to announce that RadiusXR's 'NOVA' Clinical Trial has been published in Association for Research in Vision and Ophthalmology (ARVO)'s Translational and Vision Science journal! 📚 Our innovative approach highlights statistical non-inferiority to current clinical standards for sensitivities at individual test locations, glaucoma staging using Medicare definitions and an exceptionally high correlation of 0.94 in mean deviation. Plus, our technology measures vision within the photopic range for consistent clinical training. 🌟 Leading ophthalmologists are hailing this as a game-changer! 🚀 Check out the full article https://buff.ly/3VnICso #RadiusXR #NOVAClinicalTrial #Innovation #OcularHealth #VisionScience
To view or add a comment, sign in
-
MBBS @University of Gezira |MRCS-RCSEngland |Doctor-SCFHS | IMG| Surgical Researcher| Aspiring Surgeon
📢 Publication alert! I'm thrilled to announce the most recent publication of our study entitled: “ Comparing the efficacy of endoscopic endonasal versus microscopic transsphenoidal approach for the management of sellar and suprasellar tumors: a systematic review and meta-analysis protocol” which has been published in the Oxford Journal of Surgical Protocols and Research Methodologies. 💡You can read the full article through the link provided below: https://lnkd.in/d8D4f2XG #puplication #researchstudy #neuorosurgery #glioblastoma #Lowintensityultrasound #gbm #oxford #SystamaticReviews #PRP #TBI #platelet_rich_plasma #traumatic_brain_injury
To view or add a comment, sign in
-
OpRegen®(RG6501) Preclinical Engraftment Results to be Presented at the 2024 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. Read here: https://bit.ly/3Tu4voC @Retina Today #ReplaceandRestore #Retina
To view or add a comment, sign in
-
📣 Sign up for our July 11 webinar! Our experts Todd Rudo, Amit Vasanji, and Kelly Dumais will explore strategies to enhance patient access and precision analysis using artificial intelligence (#AI) in ophthalmology clinical trials. We’ll dive into: ▫️Vendor-agnostic, multi-modality platforms ▫️AI-enabled workflows ▫️Best practices for eCOA implementation in various trial settings ➡️ Register now and don’t miss the opportunity to learn how AI transforms ophthalmology clinical trials: https://lnkd.in/eJYY7Rgf #artificialintelligence #clinicaltrials #ophthalmology
To view or add a comment, sign in
-
The Future is Here. Witness some great science being discussed at LVPEI.. #genetherapy #celltherapy #cellandgenetherapy #cgt #personalisedmedicine #gmp #opthalmology #oculargenetherapy
Grab the opportunity to witness some exciting advancements in Biomaterials and therapeutics revolving around the field of Ophthalmology. A great event to understand why and how we do, what we do. Come, join us to explore, experiment, and enjoy! Registration details are available @ https://lnkd.in/edw8dgpf Sayan Basu Arkasubhra Ghosh Dr Vivek Singh (Organisers) L V Prasad Eye Institute (LVPEI) This meeting is supported by #DBT India (CTEP) #SERB
To view or add a comment, sign in
-
Thrilled about the buzz surrounding the Eyerising Myopia Management Device on the first day of The Association for Research in Vision and Ophthalmology Annual Meeting (ARVO'24)! Packed house at Professor Mingguang He's presentation on Repeated Low-Level Red-Light Technology—definitely an enlightening session. Looking forward in catching up with you at our stand if you are at the conference! #ARVO24 #Eyerisinginternational #MyopiaManagement"
To view or add a comment, sign in
-
Watch a short presentation of our CEO explaining how @NovaSight is planning to fight the myopia epidemic 🤓
For those of you who didn’t have a chance to hear our CEO & Co-Founder, Ran Yam, taking the stage at the 2024 European Ophthalmology Futures Forums, now have the opportunity to see the presentation’s recording where Ran shares the latest updates on CureSight™ commercialization progress, and TrackSight™, our innovative AI-based eye tracking myopia prevention solution. During his presentation, Ran shared insights on the current myopia management landscape solutions, highlighting TrackSight’s advantages and our planned clinical roadmap to tackle this growing global challenge. For the full presentation - https://lnkd.in/dehyziHs Want to stay up to date with our myopia prevention efforts and the company’s commercial activities? Leave your contact details in the link in the first comment. #myopia #visionhealth #amblyopia #eyetracking #ophthalmology
Ophthalmology Futures Forums (European) - Ram Yam
https://www.youtube.com/
To view or add a comment, sign in
25,902 followers